Reference desk / Entry
BPC-157
Read the scope first. Then use the note and questions to examine what the evidence can answer.
- Scoped product status
- Not FDA-approved
- Evidence label
- Early human evidence
- Status as of
Reference fields
References for these fields are listed together in Sources.
- Product and use scope
- No FDA-approved BPC-157 product is established in the reviewed official evidence.
- Route context
- The pilot used an intravenous route; this is not an instruction for use.
- Mechanism
- This evidence does not establish a human therapeutic mechanism.
- Evidence
- A very small, uncontrolled human pilot has been published.
- Limitations
- That observation cannot establish injury repair or long-term safety.
- Safety
- FDA considers clinical safety information insufficient.
A question worth making clear
Place the question you brought to a report beside the conclusion it actually offers. Compare their subject, outcome, and conditions before deciding whether they fit. If the conclusion addresses only part of the question, mark that part and describe the missing connection. A relevant reference need not provide the complete answer, and an incomplete answer need not be irrelevant. This distinction helps readers make a specific request for further evidence. It also prevents agreement that a report is interesting from being mistaken for agreement that it settles the issue under discussion.
- Which part of our original question does the conclusion directly address?
- What connection would be needed to answer the part that remains open?
- Are we agreeing that this report is relevant or that it answers the whole question?
Sources
Each date below belongs to the supplied source record. The references support the entry as a group.
- Lee
PubMed · Checked
- FDA BPC-157
FDA · Checked